The purpose of this task order is to procure services for storage and stability vaccine bulk lots from prior contracts for U.S. Department of defense (DOD) under IDIQ contract 75A50122D00002 during…
Ended Awarded Last action
- Contract number
- 75A50122F61002
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $62,952
Award facts
- Contract value 100% obligated
- $62,952.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $62,952 |
About this award
The Office of the Assistant Secretary for Preparedness and Response issued a $62,952 firm-fixed-price delivery order to Glaxosmithkline, LLC on February 22, 2022, under IDIQ contract 75A50122D00002. The order procures storage and stability services for vaccine bulk lots from prior contracts, performed for the U.S. Department of Defense during the base period. Glaxosmithkline is a foreign-owned, for-profit manufacturer that holds no SBA set-aside designations, and the order was issued without set-aside. Place of performance is Durham, NC 27709. Period of performance runs from February 22, 2022 through February 21, 2023. The record's description also references a modification activating the Invoice Processing Platform for this order.
Description
The purpose of this task order is to procure services for storage and stability vaccine bulk lots from prior contracts for U.S. Department of defense (DOD) under IDIQ contract 75A50122D00002 during base period.
Quick answers
Who was awarded contract 75A50122F61002?
75A50122F61002 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on February 22, 2022.
How much is contract 75A50122F61002 worth?
The government has obligated $62,952 on 75A50122F61002.
Is contract 75A50122F61002 an order under another contract?
Yes. 75A50122F61002 is a delivery order under 75A50122D00002, an indefinite delivery contract.
Was contract 75A50122F61002 competed?
The extent of competition for 75A50122F61002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award